Epidemiology Report on EpiCast Report Atrial Fibrillation Market Forecast to 2023
Big Market Research, EpiCast Report: Atrial Fibrillation Epidemiology Market Size, Share, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities, Segmentation, to 2023. Browse complete report & TOC @ http://www.bigmarketresearch.com/epicast-report-atrial-fibrillation-epidemiology-forecast-to-2023-market Atrial fibrillation (AF) is a disorder of the heart’s electrical system. AF is one of the most common cardiovascular diseases among the elderly, worldwide. According to the Global Burden of Disease study, AF affected approximately 33.5 million people, or 0.5% of the world''s population, in 2010, of which 20.9 million were men and 12.6 million were women. The disease burden is likely to increase in the near future due to the projected increase in the population, especially the elderly population. Researcher epidemiologists forecast that the diagnosed prevalent cases of AF in the 8MM will grow by 21.8% over the next decade, from 10,112,797 diagnosed prevalent cases in 2013 to 12,316,458 diagnosed prevalent cases in 2023. Researcher epidemiologists attribute the growth in the diagnosed prevalent cases of AF in the 8MM to the changing population demographics in the respective markets, rather than an actual increase in the diagnosed prevalence of AF in these markets.
Big Market Research, EpiCast Report: Atrial Fibrillation Epidemiology Market Size, Share, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities, Segmentation, to 2023. Browse complete report & TOC @ http://www.bigmarketresearch.com/epicast-report-atrial-fibrillation-epidemiology-forecast-to-2023-market
Atrial fibrillation (AF) is a disorder of the heart’s electrical system. AF is one of the most common cardiovascular diseases among the elderly, worldwide. According to the Global Burden of Disease study, AF affected approximately 33.5 million people, or 0.5% of the world''s population, in 2010, of which 20.9 million were men and 12.6 million were women. The disease burden is likely to increase in the near future due to the projected increase in the population, especially the elderly population. Researcher epidemiologists forecast that the diagnosed prevalent cases of AF in the 8MM will grow by 21.8% over the next decade, from 10,112,797 diagnosed prevalent cases in 2013 to 12,316,458 diagnosed prevalent cases in 2023. Researcher epidemiologists attribute the growth in the diagnosed prevalent cases of AF in the 8MM to the changing population demographics in the respective markets, rather than an actual increase in the diagnosed prevalence of AF in these markets.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<str<strong>on</strong>g>Report</str<strong>on</strong>g> Descripti<strong>on</strong><br />
AF is <strong>on</strong>e of the most comm<strong>on</strong> cardiovascular diseases am<strong>on</strong>g the elderly, worldwide.<br />
Although AF affects people of all ages, the c<strong>on</strong>diti<strong>on</strong> is rare in individuals younger than 40<br />
years of age. The risk for AF increases rapidly with age and is more comm<strong>on</strong> in men than<br />
women. Globally, the prevalence of AF varies widely, depending <strong>on</strong> the country and the<br />
study, ranging from 0.1-1.6% in Asia (0.1% in India, 1.6% in Japan), 0.95-3.9% in North<br />
America (0.95% in the US, 3.9% in Canada), 1.28-2.1% in Europe (1.28% in the UK, 2.1% in<br />
Germany), and 4.0% in Australia.<br />
GlobalData epidemiologists forecast that the diagnosed prevalent cases of AF in the 8MM<br />
will grow by 21.8% over the next decade, from 10,112,797 diagnosed prevalent cases in<br />
2013 <strong>to</strong> 12,316,458 diagnosed prevalent cases in <strong>2023</strong>.<br />
Feel free <strong>to</strong> enquire about this report @<br />
http://www.bigmarketresearch.com/report-enquiry/190797
Change language